V R Dev|B Heeringa|R Busch

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

V R Dev

B Heeringa

R Busch

Showing results (581-590 of 608) with videos related to

Pageof 61

Sort By:

United European Gastroenterology Journal|June 5, 2026

Endoscopic Ultrasonography-Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health-Economic Evaluation Alongside a Randomized TrialYorick L van de Pavert, Kirsten Opmeer, Marc G Besselink, et al.

HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2026

Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic modelsAmmar A Javed, Mahsoem Ali, Omar Mahmud, et al.

JAMA Surgery|October 8, 2025

Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.

BMC Cancer|August 7, 2023

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025

Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017

Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.

Annals of Surgery|December 15, 2017

Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.

Trials|April 9, 2017

Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trialThijs de Rooij, Jony van Hilst, Jantien A Vogel, et al.

Journal of the National Cancer Institute|September 3, 2025

Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinomaAmmar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.

Pageof 61

Search research articles

Showing results (581-590 of 608) with videos related to

Sort By:

Pageof 61

United European Gastroenterology Journal|June 5, 2026

HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2026

JAMA Surgery|October 8, 2025

Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.

BMC Cancer|August 7, 2023

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025

Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017

Annals of Surgery|December 15, 2017

Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.

Trials|April 9, 2017

Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trialThijs de Rooij, Jony van Hilst, Jantien A Vogel, et al.

Journal of the National Cancer Institute|September 3, 2025

Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinomaAmmar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.

Pageof 61